Cara Therapeutics Inc.

4.94
-0.13 (-2.56%)
At close: Apr 01, 2025, 3:31 PM
4.93
-0.20%
After-hours: Apr 01, 2025, 06:43 PM EDT

Cara Therapeutics Balance Sheet Statement

Year FY24 FY23 FY22 FY21 FY20
Cash & Equivalents 37.9M 51.77M 63.74M 13.45M 31.68M
Short-Term Investments n/a 48.98M 81.66M 153.58M 149.24M
Long-Term Investments n/a n/a 11.35M 69.75M 70.56M
Other Long-Term Assets n/a 1.5M -13.33M 408K 408K
Receivables 4.5M 4.02M 4.45M 1.15M 2.06M
Inventory 900K 2.82M 2.38M 2.58M -1.51M
Other Current Assets 529K 408K 408K n/a n/a
Total Current Assets 43.83M 116.16M 168.91M 173.29M 195.06M
Property-Plant & Equipment n/a 8.19M 1.98M 3.6M 5.12M
Goodwill & Intangibles n/a n/a n/a n/a n/a
Total Long-Term Assets n/a 9.69M 13.33M 73.77M 76.09M
Total Assets 43.83M 125.84M 182.24M 247.06M 271.16M
Account Payables 1.43M 11.58M 9.6M 5.63M 4.89M
Deferred Revenue n/a n/a n/a n/a n/a
Short-Term Debt n/a n/a 1.92M 1.75M 1.6M
Other Current Liabilities 2.54M 7.49M 4.8M 3.52M 5.43M
Total Current Liabilities 3.97M 25.59M 23.46M 17.62M 18.48M
Long-Term Debt n/a 37.08M n/a 1.92M 3.67M
Other Long-Term Liabilities 44.45M n/a n/a -1.92M -3.67M
Total Long-Term Liabilities 44.45M 43.17M 11.52M 1.92M 3.67M
Total Liabilities 48.42M 68.76M 23.46M 19.53M 22.16M
Total Debt n/a 43.17M 1.92M 3.67M 5.28M
Common Stock 5K 54K 53K 53K 50K
Retained Earnings -755.61M -684.75M -566.23M -480.76M -392.32M
Comprehensive Income n/a -260K -1.67M -358K 73K
Shareholders Equity -4.59M 57.09M 158.78M 227.52M 249M
Total Investments n/a 48.98M 93.01M 223.34M 219.81M